Section 1Citation and commencement
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
資料由法律人 LawPlayer整理提供·UK legislation / curated by LawPlayer from legislation.gov.uk
Statutory InstrumentNot in force
The National Health Service (Pharmaceutical Services) Regulations 2012 (revoked)
Section 2Interpretation
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 3Pharmaceutical needs assessments
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 4Information to be contained in pharmaceutical needs assessments
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 5Date by which the first pharmaceutical needs assessment is to be published
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 6Subsequent assessments
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 7Temporary extension of pharmaceutical needs assessments
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 8Consultation on pharmaceutical needs assessments
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 9Matters for consideration when making assessments
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 10Pharmaceutical lists and EPS lists
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 11Terms of service of NHS chemists: general
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 12Routine applications for inclusion in or amendment to a pharmaceutical list
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 13Current needs: additional matters to which the Primary Care Trust must have regard
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 14Current needs: consequences of additional matters
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 15Future needs: additional matters to which the Primary Care Trust must have regard
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 16Future needs: consequences of additional matters
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 17Improvements or better access in the pharmaceutical needs assessment: additional matters to which the Primary Care Trust must have regard
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 18Unforeseen benefits applications: additional matters to which the Primary Care Trust must have regard
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 19Applications to which regulation 17 or 18 applies: consequences of additional matters
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 20Future improvements or better access: additional matters to which the Primary Care Trust must have regard
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 21Future improvements or better access: consequences of additional matters
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 22Refusal of routine applications that are based on neither a pharmaceutical needs assessment nor unforeseen benefits
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 23Applications from NHS chemists in respect of providing directed services
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 24Relocations that do not result in significant change to pharmaceutical services provision
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 25Distance selling premises applications
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 26Change of ownership applications
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 27Applications for temporary listings arising out of suspensions
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 28Applications from persons exercising a right of return to a pharmaceutical list
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 29Applications relating to emergencies requiring the flexible provision of pharmaceutical services
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 30Refusal: language requirement for some NHS pharmacists
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 31Refusal: same or adjacent premises
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 32Deferrals arising out of LPS designations
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 33Refusal of applications for inclusion in a pharmaceutical list on fitness grounds
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 34Deferral of consideration of applications for inclusion in a pharmaceutical list on fitness grounds
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 35Granting applications for inclusion in a pharmaceutical list subject to efficiency conditions and conditions to combat fraud
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 36Determination that an area is a controlled locality
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 37Process for determining controlled localities: preliminary matters
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 38Process for determining controlled localities: local notification and deferment of routine applications
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 39Process of determining controlled localities: formulation of the Primary Care Trust’s decision
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 40Applications for new pharmacy premises in controlled localities: refusals because of preliminary matters
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 41Applications for new pharmacy premises in controlled localities: reserved locations
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 42Second and subsequent determinations of reserved location status
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 43Determinations of reserved locations: supplemental matters
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 44Prejudice test in respect of routine applications for new pharmacy premises in a part of a controlled locality that is not a reserved location
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 45Appeals against decisions under Part 7
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 46Dispensing doctor lists
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 47Terms of service of dispensing doctors: general
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 48Arrangements for the provision of pharmaceutical services by doctors: applications by patients
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 49Necessary services for temporary patients
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 50Discontinuation of arrangements for the provision of pharmaceutical services by doctors
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
256 sections
Cite this legislation
The National Health Service (Pharmaceutical Services) Regulations 2012 (revoked) (legislation.gov.uk, OGL v3.0). Retrieved via LawPlayer, https://lawplayer.com/uk/act/uksi-2012-1909
Contains public sector information licensed under the Open Government Licence v3.0.
本頁資料來源：legislation.gov.uk (The National Archives)·整理提供：法律人 LawPlayer· lawplayer.com